The McKinsey Week in Charts

All chips are on the table

With demand for chips continuing to outstrip supply, strong growth is possible for all semiconductor companies, regardless of size. While quartile 1 shows that the largest companies generate the greatest profits, our analysis also found small, niche players with high operating margins.

To read the article, see “Strategies to lead in the semiconductor world,” April 15, 2022.

A little help from hybrid

Organisations are still figuring out the best ways to make flexible workplace models meet the needs of their workers, but some benefits are beginning to emerge. Employees responding to a McKinsey survey say inclusion practices such as mutual respect and work–life support have gotten better at their companies thanks to the hybrid work environment.

To read the article, see “Hybrid work: Making it fit with your diversity, equity, and inclusion strategy,” April 20, 2022.

 

Charging ahead

The automotive industry’s focus on autonomous driving, connected cars, electric vehicles, and shared mobility (ACES) is prompting automotive suppliers to adapt. The McKinsey and the European Association of Automotive Suppliers survey revealed that 90 % of suppliers said they were reshaping their portfolio mix to focus on technology-driven components while de-emphasising hardware.

To read the article, see “Amid disruption, automotive suppliers must reimagine their footprints,” April 19, 2022.

Make way for new players

In 2020, some 70 % of new clinical trials were sponsored by smaller pharma companies, up from 60 % in 2016. Unprecedented levels of venture-capital investment and increasing availability and breadth of outsourced capacity and capabilities paved the way for smaller companies to pursue innovation.

To read the article, see “Building pharma pipelines using a socioeconomic lens,” April 8, 2022.

 

We’ve only just begun

FemTech companies typically build largely tech-enabled, consumer-centric solutions addressing women’s health. While start-ups in this space are proliferating, there remains opportunities for innovation in services and support of menstrual health, menopause, and contraception as well as new products and devices.

To read the article, see “The dawn of the FemTech revolution,” February 14, 2022.

 

www.mckinssey.com